Aehr Test SystemsAEHRNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank49
3Y CAGR+6.9%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+6.9%/yr
Quarterly compound
Percentile
P49
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.32% |
| Q3 2025 | 6.07% |
| Q2 2025 | -14.46% |
| Q1 2025 | 37.96% |
| Q4 2024 | -3.60% |
| Q3 2024 | 9.76% |
| Q2 2024 | 0.56% |
| Q1 2024 | 8.47% |
| Q4 2023 | -19.74% |
| Q3 2023 | 9.05% |
| Q2 2023 | 22.98% |
| Q1 2023 | 18.12% |
| Q4 2022 | 3.54% |
| Q3 2022 | -9.49% |
| Q2 2022 | 8.24% |
| Q1 2022 | 16.45% |
| Q4 2021 | -0.61% |
| Q3 2021 | 28.38% |
| Q2 2021 | 13.95% |
| Q1 2021 | 10.12% |
| Q4 2020 | -8.89% |
| Q3 2020 | 5.39% |
| Q2 2020 | 1.07% |
| Q1 2020 | 6.29% |
| Q4 2019 | -10.87% |
| Q3 2019 | -20.36% |
| Q2 2019 | 20.30% |
| Q1 2019 | -5.58% |
| Q4 2018 | -11.65% |
| Q3 2018 | 1.82% |
| Q2 2018 | 5.38% |
| Q1 2018 | -4.59% |
| Q4 2017 | 14.14% |
| Q3 2017 | -27.04% |
| Q2 2017 | 4.89% |
| Q1 2017 | 20.00% |
| Q4 2016 | -1.89% |
| Q3 2016 | 1.34% |
| Q2 2016 | -19.10% |
| Q1 2016 | 40.09% |